EU-MEDICAL_DEVICES-ANX_I_7_8
EU-MEDICAL_DEVICES-ANX_I_7_8
Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Directive 93/42/EEC, 12 July 1993, amended by Directive 2007/47/EC, 21 September 2007
This list contains hazardous substances in accordance with the Medical Devices Directive's (MDD) design and construction requirements pursuant to Annex I, Part II (7) & (8) (i.e., chemical, physical and biological properties; and infection and microbial contamination). Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 93/42/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.
Last updated 25 April 2024. Database contains 4753 unique substances/entries.
Filter the list
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
show/hide
Acetic acid, (2,4-dichlorophenoxy)-, 2-(propoxy-methoxy)ethyl ester
EC / List no:
-
| CAS no:
59577-69-4
Acetic acid, (2,4-dichlorophenoxy)-, 2-[(pentyloxy)-methoxy]ethyl ester
EC / List no:
-
| CAS no:
59577-71-8
Acetic acid, (2,4-dichlorophenoxy)-, (4-((4-chlorophenyl)sulfinyl)-3-nitrophenyl)methyl ester
EC / List no:
-
| CAS no:
66711-20-4
Acetic acid, (2,4-dichlorophenoxy)-, 2-(butoxy-methoxy)ethyl ester
EC / List no:
-
| CAS no:
59577-70-7
(2,4-Dichlorophenoxy)acetic acid, (4-hydroxy-3-nitrophenyl)methyl ester
EC / List no:
-
| CAS no:
26351-71-3
2,4-Dichlorophenoxyacetic acid 2-dimethylaminoethyl ester hydrochloride
EC / List no:
-
| CAS no:
64046-52-2
Acetic acid, (2,4-dichlorophenoxy)-, 2-chloro-4-nitrophenyl ester
EC / List no:
-
| CAS no:
53640-16-7
Acetic acid, (2,4-dichlorophenoxy)-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, endo-
EC / List no:
-
| CAS no:
40797-15-7
Acetic acid, (2,4-dichlorophenoxy)-, 2-[(octyloxy)-methoxy]ethyl ester
EC / List no:
-
| CAS no:
59577-73-0
Acetic acid, (2,4-dichlorophenoxy)-, 2-methoxy-cyclohexyl ester
EC / List no:
-
| CAS no:
52176-65-5
Acetic acid, (2,4-dichlorophenoxy)-, 2-[(heptyloxy)-methyl]ethyl ester
EC / List no:
-
| CAS no:
59577-74-1
Acetic acid, (2,4-dichlorophenoxy)-, 2-[(2-chloroethoxy)methoxy]ethyl ester
EC / List no:
-
| CAS no:
59577-75-2
Acetic acid, (2,4-dichlorophenoxy)-, [4-[(4-methylphenyl)sulfinyl]-3-nitrophenyl]methyl ester
EC / List no:
-
| CAS no:
66711-19-1
Acetic acid, (2,4-dichlorophenoxy)-, ester with 4-hydroxycoumarin
EC / List no:
-
| CAS no:
7565-90-4
Acetic acid, (2,4-dichlorophenoxy)-, 2-(dipropylamino)-1-methylethyl ester
EC / List no:
-
| CAS no:
15887-75-9
Acetic acid, (2,4-dichlorophenoxy)-, (2-chloroethyl)dimethylsilyl ester
EC / List no:
-
| CAS no:
51663-83-3
Acetic acid, (2,4-dichlorophenoxy)-, ethenyl ester, homopolymer
EC / List no:
-
| CAS no:
55972-44-6
Acetic acid, (2,4-dichlorophenoxy)-, tetrahydro-2-furanyl ester
EC / List no:
-
| CAS no:
51822-88-9
Acetic acid, (2,4-dichlorophenoxy)-, 2,3,3-trichloro-2-propenyl ester
EC / List no:
-
| CAS no:
29670-84-6
Acetic acid, (2,4-dichlorophenoxy)-, 2-[(hexyloxy)-methoxy]ethyl ester
EC / List no:
-
| CAS no:
59577-72-9
Acetic acid, (2,4-dichlorophenoxy)-, 2-(ethoxy-methoxy)ethyl ester
EC / List no:
-
| CAS no:
59577-68-3
Nitrilotri-2,1-ethanediyl tris[(2,4-dichlorophenoxy)acetate]
EC / List no:
299-308-8
| CAS no:
93858-74-3
Acetic acid, (2,4-dichlorophenoxy)-, 4-chloro-2-nitrophenyl ester
EC / List no:
-
| CAS no:
53640-15-6
Acetic acid, (2,4-dichlorophenoxy)-, 4-pyridinyl ester, N-oxide
EC / List no:
-
| CAS no:
54718-52-4
Acetic acid, (2,4-dichlorophenoxy)-, 3,3-difluoro-2-propenyl ester
EC / List no:
-
| CAS no:
840-85-7
Acetic acid, (2,4-dichlorophenoxy)-, 1-methyl-2,4-dioxo-3-phenyl-4-imidazolidinyl ester
EC / List no:
-
| CAS no:
56402-60-9
Acetic acid, (2,4-dichlorophenoxy)-, (3-nitro-4-(phenylsulfinyl)phenyl)methyl ester
EC / List no:
-
| CAS no:
66711-18-0
Acetic acid, (2,4-dichlorophenoxy)-, 2-(1-oxopro-poxy)ethyl ester
EC / List no:
-
| CAS no:
42313-94-0
Acetic acid, (2,4-dichlorophenoxy)-, (pentafluorophenyl)methyl ester
EC / List no:
-
| CAS no:
68704-50-7
Acetic acid, (2,4-dichlorophenoxy)-, (2-bromoethyl)-dimethylsilyl ester
EC / List no:
-
| CAS no:
51663-84-4
|
-
|
-
|
Acute Tox. 4; Skin Sens. 1 |
||
|
-
|
-
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
-
|
-
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
Acute Tox. 2 |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
Carc. 2 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||